Taken together, these results support Jab1 as a direct downstream transcriptional target of MED1 in HER2+ breast tumors that can also reciprocally regulate MED1 ubiquitination and cyclic promoter recruitment (Figure 7K). The gene discussed is MED1; the disease is breast neoplasm.